[go: up one dir, main page]

ES2038603T3 - Empleo de oligopeptidos para el tratamiento de transtornos cerebrales. - Google Patents

Empleo de oligopeptidos para el tratamiento de transtornos cerebrales.

Info

Publication number
ES2038603T3
ES2038603T3 ES198787100072T ES87100072T ES2038603T3 ES 2038603 T3 ES2038603 T3 ES 2038603T3 ES 198787100072 T ES198787100072 T ES 198787100072T ES 87100072 T ES87100072 T ES 87100072T ES 2038603 T3 ES2038603 T3 ES 2038603T3
Authority
ES
Spain
Prior art keywords
treatment
oligopeptides
brain disorders
tryptophan
sleeplessness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787100072T
Other languages
English (en)
Inventor
Klaus Dr. Rer. Nat. Sommermeyer
Burghard Dr. Med. Weidler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius SE and Co KGaA
Original Assignee
Fresenius SE and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius SE and Co KGaA filed Critical Fresenius SE and Co KGaA
Application granted granted Critical
Publication of ES2038603T3 publication Critical patent/ES2038603T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL EMPLEO DE OLIGOPEPTIDOS, EN LOS QUE AL MENOS UNO DE LOS AMINOACIDOS ENLAZADOS ES L-TRIPTOFANO, O UN AMINOACIDO DERIVADO DEL MISMO, COMO 5-HIDROXI-L-TRIPTOFANO, P.E. L-ALANIL-LTRIPTOFANO, L-TRIPTIL-L-TRIPTOFANO O L-GLICIL-LTRIPTOFANO, OPCIONALMENTE EN COMBINACION CON L-TRIPTOFANO, PARA EL TRATAMIENTO DE TRASTORNOS CEREBRALES, ESPECIALMENTE INSOMNIO Y DEPRESIONES, ASI COMO PREPARACIONES FARMACEUTICAS QUE CONTIENEN OLIGOPEPTIDOS DE ESTE TIPO, OPCIONALMENTE EN COMBINACION CON L-TRIPTOFANO, PARA EL TRATAMIENTO DE TRASTORNOS CEREBRALES, ESPECIALMENTE IMSOMNIO Y DEPRESIONES.
ES198787100072T 1986-01-18 1987-01-06 Empleo de oligopeptidos para el tratamiento de transtornos cerebrales. Expired - Lifetime ES2038603T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601398 DE3601398A1 (de) 1986-01-18 1986-01-18 Verwendung von oligopeptiden zur behandlung von cerebralen stoerungen

Publications (1)

Publication Number Publication Date
ES2038603T3 true ES2038603T3 (es) 1993-08-01

Family

ID=6292132

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787100072T Expired - Lifetime ES2038603T3 (es) 1986-01-18 1987-01-06 Empleo de oligopeptidos para el tratamiento de transtornos cerebrales.

Country Status (7)

Country Link
US (1) US4849408A (es)
EP (1) EP0234186B1 (es)
JP (1) JPS62169730A (es)
AT (1) ATE69163T1 (es)
DE (2) DE3601398A1 (es)
ES (1) ES2038603T3 (es)
GR (1) GR3003244T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823464A1 (de) * 1988-07-11 1990-01-18 Asta Pharma Ag Neue tryptophandipeptide
US5759991A (en) * 1990-03-29 1998-06-02 Sumitomo Pharmaceutical Company, Limited. Neurotrophic peptide derivatives
US5354738A (en) * 1992-09-04 1994-10-11 G. D. Searle & Co. Platelet aggregation inhibitors
US5438075A (en) 1993-03-30 1995-08-01 Skubitz; Keith M. Oral glutamine to reduce stomatitis
WO2000069470A2 (en) * 1999-05-17 2000-11-23 Aesgen, Inc. Improved cellular uptake of bioactive agents
JP4664071B2 (ja) * 2002-08-01 2011-04-06 エーザイ コーポレーション オブ ノース アメリカ グルタミンによるガンの改良治療
PT1573323E (pt) * 2002-12-03 2012-01-10 Univ North Carolina State Ligandos a proteína de prião e métodos de uso
RU2663691C2 (ru) * 2013-12-13 2018-08-08 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Фармацевтическая композиция амида n-(6-фенилгексаноил)глицил-l-триптофана с пленочным покрытием и способы ее получения
CA3061340A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
JPS51115909A (en) * 1975-04-01 1976-10-13 Otsuka Pharmaceut Factory Inc A process for preparing amino acid parenteral injection mixed with a r educing sugar
US4110438A (en) * 1977-03-21 1978-08-29 American Home Products Corporation Method of treating depression
US4405629A (en) * 1979-05-07 1983-09-20 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
IT1148618B (it) * 1982-10-11 1986-12-03 Polifarma Spa Procedimento enzimatico per la produzione di acido 3-indolpiruvico e utilizzazione farmaceutica di questo
GB8319174D0 (en) * 1983-07-15 1983-08-17 Erba Farmitalia Biologically active heptapeptides
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
ATE99698T1 (de) * 1985-10-14 1994-01-15 Nippon Zoki Pharmaceutical Co Peptide.

Also Published As

Publication number Publication date
EP0234186A1 (de) 1987-09-02
ATE69163T1 (de) 1991-11-15
US4849408A (en) 1989-07-18
DE3601398A1 (de) 1987-07-23
GR3003244T3 (en) 1993-02-17
EP0234186B1 (de) 1991-11-06
DE3774291D1 (de) 1991-12-12
JPS62169730A (ja) 1987-07-25

Similar Documents

Publication Publication Date Title
AR241103A1 (es) "dispositivo de rebajamiento del ala de una butaca anatomica envolvente para el vehiculo automotor o analogo, y butaca que comprende dicho dispositivo".
CS553490A3 (en) Transdermal therapeutic system
NO911624D0 (no) Farmasoeytiske forbindelser.
GR3006630T3 (es)
ATE38772T1 (de) Neigungsverstellbare liege zur koerperdehnung.
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
GR3006073T3 (es)
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
ES2038603T3 (es) Empleo de oligopeptidos para el tratamiento de transtornos cerebrales.
EP0326023A3 (en) Benzamide against cognitive disorders
ES2041845T3 (es) Empleo de 2-oxo-pirrolidon-1-acetamida para la determinacion de las velocidades glomerulares de filtracion en seres humanos.
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ES2094898T3 (es) Procedimiento para la produccion de la proteina c activada.
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
ZA929390B (en) The use of D-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects.
EP0516914A3 (en) Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ZA88922B (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
IL89901A0 (en) Strobilurine derivatives
DE3378979D1 (en) 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents
ES2087764T3 (es) Uso del ajo de oso en el tratamiento o prevencion de los trastornos circulatorios.
BR9808063A (pt) Métodos para tratamento de distúrbios vasculares.
ES2018613B3 (es) Procedimiento y dispositivo para la depuracion de aguas contaminadas.
ES2153854T3 (es) Uso de compuestos de triazina para el tratamiento de trastornos de la memoria y del aprendizaje.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 234186

Country of ref document: ES